BioCorRx (BICX) Non-Current Debt (2010 - 2026)
BioCorRx (BICX) posted Non-Current Debt of $69155.0 for Q1 2026, down 0.55% sequentially from $69537.0 in Q4 2025, and down 86.17% YoY from $500000.0 in Q1 2025.
BioCorRx (BICX) Non-Current Debt (2010 - 2026) Analysis & Trends
BioCorRx has reported Non-Current Debt for 17 years, with the latest figure at $69155.0 in Q1 2026.
- Quarterly Non-Current Debt fell 86.17% year-over-year to $69155.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $69155.0 (down 86.17% YoY) and the FY2025 annual result came in at $69537.0, down 2.1% from the prior year.
- Non-Current Debt slipped to $69155.0 in Q1 2026 per BICX's latest filing, from $69537.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $500000.0 in Q1 2022 and troughed at $69155.0 in Q1 2026.
- A 5-year average of $322844.9 and a median of $359729.0 in 2023 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2025 and 2026: Non-Current Debt surged 241.47% in 2025, then plunged 86.17% in 2026.
- Over 5 years, Non-Current Debt stood at $297602.0 in 2022, then soared by 68.01% to $500000.0 in 2023, then sank by 85.79% to $71029.0 in 2024, then retreated by 2.1% to $69537.0 in 2025, then fell by 0.55% to $69155.0 in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $69155.0, $69537.0, and $69803.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 45.83 Bn |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 13.09 Bn |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 2.60 Bn |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 10.66 Bn |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 135.56 Mn |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 4.90 Bn |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 238.71 Mn |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 140.00 Mn |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 1.56 Bn |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 69,155.00 |
| Dec 31, 2025 | 69,537.00 |
| Sep 30, 2025 | 69,803.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Dec 31, 2024 | 71,029.00 |
| Sep 30, 2024 | 500,000.00 |
| Jun 30, 2024 | 146,426.00 |
| Mar 31, 2024 | 146,426.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | 408,238.00 |
| Jun 30, 2023 | 359,729.00 |
| Mar 31, 2023 | 350,418.00 |
| Dec 31, 2022 | 297,602.00 |
| Sep 30, 2022 | 500,000.00 |
| Jun 30, 2022 | 500,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 99,860.00 |
| Dec 31, 2020 | 21,480.00 |
| Jun 30, 2020 | 290,110.00 |